Levothyroxine Sodium
- Product NDC
- 70860-451
- 11-digit product format
- 708600451
- Labeler code
- 70860
- Product ID
- 70860-451_beba3892-9b9f-4786-9ebb-b70076071295
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- levothyroxine sodium anhydrous
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA208749
- Marketing category
- ANDA
- Marketing start
- 2018-12-15
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM ANHYDROUS
- Active strength
- 100 ug/5mL
- Pharmacologic classes
- l-Thyroxine [EPC],Thyroxine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-451-10 | 70860045110 | 1 VIAL in 1 CARTON (70860-451-10) > 5 mL in 1 VIAL | 1 vial | 2018-12-15 | 0000-00-00 | No | No | Current |